BROWN MORGAN R
Insider CIK 1266062 · INNV See remarks · LPCN Executive Vice President/CFO · CLNN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLNN Clene Inc. | A Award deriv | 2026-10-20 | 2026-10-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2026-01-22 | 2026-01-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2025-09-25 | 2025-09-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2025-09-18 | 2025-09-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2025-02-24 | 2025-02-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2024-08-16 | 2024-08-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2023-06-29 | 2023-07-03 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2023-02-17 | 2023-02-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2022-11-04 | 2022-11-07 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2021-12-07 | 2021-12-08 | 176,000 | $1.12 | $197.1K | 176,000 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2020-12-16 | 2020-12-17 | 28,125 | — | $0 | 28,125 | SEC↗ |
| LPCN Lipocine Inc. | S Sale | 2020-12-16 | 2020-12-17 | 8,437 | $1.35 | $11.4K | 194,504 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2020-12-16 | 2020-12-17 | 28,125 | — | $0 | 202,941 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2020-12-15 | 2020-12-17 | 160,000 | $1.37 | $219.2K | 160,000 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2020-12-05 | 2020-12-08 | 70,754 | — | $0 | 70,754 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2020-12-05 | 2020-12-08 | 70,754 | — | $0 | 174,816 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2020-12-04 | 2020-12-08 | 57,500 | — | $0 | 57,500 | SEC↗ |
| LPCN Lipocine Inc. | S Sale | 2020-12-04 | 2020-12-08 | 17,250 | $1.57 | $27.1K | 104,062 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2020-12-04 | 2020-12-08 | 57,500 | — | $0 | 121,312 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2020-01-28 | 2020-01-28 | 132,000 | $0.46 | $60.7K | 132,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2019-12-05 | 2019-12-06 | 70,754 | — | $0 | 70,754 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2019-12-04 | 2019-12-06 | 57,500 | — | $0 | 57,500 | SEC↗ |
| LPCN Lipocine Inc. | S Sale | 2019-12-04 | 2019-12-06 | 17,250 | $0.41 | $7.1K | 63,812 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2019-12-04 | 2019-12-06 | 57,500 | — | $0 | 81,062 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2018-12-04 | 2018-12-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2018-12-04 | 2018-12-06 | 75,000 | $1.46 | $109.5K | 75,000 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise deriv | 2017-12-29 | 2018-01-02 | 9,375 | — | $0 | 28,125 | SEC↗ |
| LPCN Lipocine Inc. | M Exercise | 2017-12-29 | 2018-01-02 | 9,375 | — | $0 | 26,375 | SEC↗ |
| LPCN Lipocine Inc. | S Sale | 2017-12-29 | 2018-01-02 | 2,813 | $3.47 | $9.8K | 23,562 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2017-12-06 | 2017-12-06 | 75,000 | $3.52 | $264.0K | 75,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 37,500 | — | $0 | 37,500 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2016-12-07 | 2016-12-08 | 50,000 | $3.61 | $180.5K | 50,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2016-01-05 | 2016-01-07 | 50,000 | $12.92 | $646.0K | 50,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2014-08-14 | 2014-08-15 | 34,268 | — | $0 | 34,268 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2013-12-10 | 2013-12-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2013-12-10 | 2013-12-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2013-09-16 | 2013-09-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award | 2013-09-16 | 2013-09-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2013-05-28 | 2013-05-30 | 750,000 | — | $0 | 750,000 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award | 2013-05-28 | 2013-06-28 | 750,000 | — | $0 | 750,000 | SEC↗ |